2014 Fiscal Year Final Research Report
Dvelopment of novel anti-obesity agents targeting cell-surface F1F0-ATP synthase
Project/Area Number |
24590081
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Biological pharmacy
|
Research Institution | The University of Tokushima |
Principal Investigator |
ARAKAKI Naokatu 徳島大学, ヘルスバイオサイエンス研究部, 准教授 (60151148)
|
Co-Investigator(Kenkyū-buntansha) |
YAMAZAKI Tetsuo 徳島大学, 大学院ヘルスバイオサイエンス研究部, 教授 (90330208)
NEMOTO Hisao 徳島大学, 大学院ヘルスバイオサイエンス研究部, 准教授 (30208293)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Keywords | F1Fo-ATP合成酵素 / 脂肪細胞 / 細胞内中性脂肪 / 抗肥満薬 |
Outline of Final Research Achievements |
Cell-surface F1F0-ATP synthase plays a role on intracellular triacylglycerol (TG) accumulation in adipocytes. Here we show that cell-surface F1F0-ATP synthase on adipocytes is functional in extracellular ATP production and that the extracellular ATP produced contributes, at least in part, to the cell-surface F1F0-ATP synthase-mediated intracellular triacylglycerol (TG) accumulation in adipocytes through P2Y1 receptor. We synthesized water-soluble resveratrol and piceatannol which are F1F0-ATP synthase inhibitors) and found that these compounds significantly lowered abdominal visceral adipose tissue in diet-induced obese mice.
|
Free Research Field |
医歯薬学
|